
|Articles|April 16, 2007
Latebreakers: Combo diabetes drug gets FDA nod
The FDA has approved the combination of sitagliptin (Januvia, Merck) and metformin for the treatment of Type 2 diabetes.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain
2
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
3
Postpartum Mothers Favor Bedtime Stopping Rule Over Stricter Chrononutrition Approaches
4
What’s Next for Pneumococcal Vaccination? An Expert Weighs In
5






























